Precision BioSciences, Inc. - Common Stock — 현금 흐름 (NASDAQ:DTIL)

Financials

영업활동으로 인한 현금 -87.39 M-10.85 M-45.75 M-84.11 M-58.45 M-65.84 M -58.73 M 투자 활동으로 인한 현금 -5.03 M-5.8 M-3.32 M5.83 M-215 K-634 K -434 K 재무활동으로 인한 현금 1.33 M70.52 M94.98 M5.39 M50.45 M95.16 M 85.22 M 잉여 현금 흐름 -92.42 M-15.91 M-49.07 M-86.07 M-58.7 M-65.93 M -58.77 M

Precision BioSciences, Inc. - Common Stock

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

DTIL

Financials

Precision BioSciences, Inc. - Common Stock

뉴스

Precision BioSciences, Inc. (DTIL) Discusses Updates on PBG and HBV Program and ELIMINATE-B Trial Results - Slideshow (NASDAQ:DTIL) 2026-05-27

Precision BioSciences (DTIL) Reports Q1 Loss, Tops Revenue Estimates

Nuvation Bio Inc. (NUVB) Lags Q1 Earnings Estimates

AnaptysBio (ANAB) Surges 14.8%: Is This an Indication of Further Gains?

Cartesian Therapeutics, Inc. (RNAC) Soars 10.3%: Is Further Upside Left in the Stock?

Precision BioSciences, Inc. (DTIL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

Should You Buy Precision BioSciences (DTIL) After Golden Cross?

Precision BioSciences, Inc. (DTIL) Shareholder/Analyst Call - Slideshow (NASDAQ:DTIL) 2026-03-18

Precision BioSciences, Inc. (DTIL) Shareholder/Analyst Call Transcript

제퍼리스, Precision BioSciences 목표 주가 하향 조정

Jefferies cuts Precision BioSciences stock price target on valuation

Precision BioSciences (DTIL) Surpasses Q4 Earnings and Revenue Estimates